ShamitaBhupendraShahMD
Gastroenterology • New Orleans, LAInflammatory Bowel Disease
Ochsner Medical Center, New Orleans Medical Director, Inflammatory Bowel Disease
Dr. Shah is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1514 Jefferson Hwy
New Orleans, LA 70121Phone+1 504-842-4015
Education & Training
University of ChicagoPost-Doctoral Fellowship, 2007 - 2008
Ochsner Clinic FoundationFellowship, Gastroenterology, 2004 - 2007
Louisiana State University School of MedicineResidency, Internal Medicine, 2000 - 2003- Louisiana State University School of Medicine in New OrleansClass of 2000
Certifications & Licensure
CA State Medical License 2008 - Present
FL State Medical License 2022 - 2026
LA State Medical License 2001 - 2025
MS State Medical License 2020 - 2025
AL State Medical License 2020 - 2024
IL State Medical License 2007 - 2008- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects Start of enrollment: 2012 Jan 01
- Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis Start of enrollment: 2013 Nov 01
Publications & Presentations
PubMed
- 3 citationsRacial and Ethnic Disparities in Patients With Inflammatory Bowel Disease: An Online Survey.Shamita Shah, Alicia C Shillington, Edmond Kato Kabagambe, Kathleen L Deering, Sheena Babin
Inflammatory Bowel Diseases. 2024-09-03 - 1 citationsLetter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis.Ahmad H Ali, Cynthia W Buness, Ryan Fischer, Gerald J Holtmann, Ayesha Shah
Hepatology. 2023-06-01 - 17 citationsUlcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy.Harrison M. Penrose, Rida Iftikhar, Morgan E. Collins, Eman A. Toraih, Emmanuelle Ruiz
Scientific Reports. 2021-04-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
